PLEKHA2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-83400
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Summary for PLEKHA2 Antibody
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human PLEKHA2. Peptide sequence: LLPPGDTSEDSLFTPRPGEGAPPGVLPSSRIRHRSEPQHPKEKPFMFNLD The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for PLEKHA2 Antibody
Western Blot: PLEKHA2 Antibody [NBP2-83400]
Western Blot: PLEKHA2 Antibody [NBP2-83400] - Host: Rabbit. Target Name: PLEKHA2. Sample Type: Hela Whole Cell lysates. Antibody Dilution: 1.0ug/mlApplications for PLEKHA2 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: PLEKHA2
Alternate Names
FLJ25921, PH domain-containing family A member 2, pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2, pleckstrin homology domain-containing family A member 2, pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2, tandem PH Domain containing protein-2, tandem PH domain-containing protein 2, TAPP2, TAPP-2
Gene Symbol
PLEKHA2
Additional PLEKHA2 Products
Product Specific Notices for PLEKHA2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...